{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:01:28Z","timestamp":1793653288060,"version":"4.5.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T00:00:00Z","timestamp":1455062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The involvement of pathogenic bacteria in obstructive sleep apnoea syndrome (OSAS) has yet to be elucidated. We investigated the possible role of group A streptococcus (GAS) in OSAS pathogenesis. In 40 tonsillectomized patients affected by OSAS and 80 healthy controls, significant (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) association of GAS with paediatric OSAS was found. Supernatant from streptolysin O (SLO)-producing GAS induced production of cysteinyl leukotrienes (CysLTs) in tonsil mononuclear cells (TMCs). CysLTs-treated TMCs showed significant (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) proliferation of CD4+ T, CD19+ and CD19+CD27+CD38+ B lymphocytes. We discovered a SLO-dependent activation of CysLTs production through a pathway involving TOLL-like receptor 4 (TLR4), TIR-domain-containing adapter-inducing interferon-\u03b2 (TRIF), Myeloid differentiation primary response gene 88 (MyD88), and p38 MAP Kinase. In conclusion, we hypothesise that GAS may contribute to paediatric tonsillar hyperplasia through CysLTs production induced by SLO, and this might explain its association with OSAS.<\/jats:p>","DOI":"10.1038\/srep20609","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T10:58:32Z","timestamp":1455101912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes"],"prefix":"10.1038","volume":"6","author":[{"given":"Elisa","family":"Viciani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Tavarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinta","family":"Tordini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Maccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Faenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Salerni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oretta","family":"Finco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le A.","family":"Barocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G. O.","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"BFsrep20609_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.pcl.2013.04.015","volume":"60","author":"SD Ramos","year":"2013","unstructured":"Ramos, S. D., Mukerji, S. & Pine, H. S. Tonsillectomy and adenoidectomy. Pediatr Clin North Am 60, 793\u2013807 (2013).","journal-title":"Pediatr Clin North Am"},{"key":"BFsrep20609_CR2","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1097\/MLG.0b013e31814543c8","volume":"117","author":"JH Jeong","year":"2007","unstructured":"Jeong, J. H. et al. Bacteriologic comparison of tonsil core in recurrent tonsillitis and tonsillar hypertrophy. Laryngoscope 117, 2146\u201351 (2007).","journal-title":"Laryngoscope"},{"key":"BFsrep20609_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/archotol.129.6.634","volume":"129","author":"RA Chole","year":"2003","unstructured":"Chole, R. A. & Faddis, B. T. Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg 129, 634\u20136 (2003).","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"BFsrep20609_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/340949","volume":"35","author":"AL Bisno","year":"2002","unstructured":"Bisno, A. L., Gerber, M. A., Gwaltney, J. M., Jr., Kaplan, E. L. & Schwartz, R. H. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 35, 113\u201325 (2002).","journal-title":"Clin Infect Dis"},{"key":"BFsrep20609_CR5","doi-asserted-by":"crossref","unstructured":"Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. Am J Respir Crit Care Med 153, 866\u201378 (1996).","DOI":"10.1164\/ajrccm.153.2.8564147"},{"key":"BFsrep20609_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1542\/peds.2012-1671","volume":"130","author":"CL Marcus","year":"2012","unstructured":"Marcus, C. L. et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 130, 576\u201384 (2012).","journal-title":"Pediatrics"},{"key":"BFsrep20609_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1378\/chest.126.1.13","volume":"126","author":"AD Goldbart","year":"2004","unstructured":"Goldbart, A. D. et al. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest 126, 13\u20138 (2004).","journal-title":"Chest"},{"key":"BFsrep20609_CR8","doi-asserted-by":"crossref","unstructured":"Zautner, A. E. Adenotonsillar disease. Recent Pat Inflamm Allergy Drug Discov 6, 121\u20139 (2012).","DOI":"10.2174\/187221312800166877"},{"key":"BFsrep20609_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1517\/13543784.2013.735230","volume":"22","author":"L Kheirandish-Gozal","year":"2013","unstructured":"Kheirandish-Gozal, L., Kim, J., Goldbart, A. D. & Gozal, D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs 22, 71\u201385 (2013).","journal-title":"Expert Opin Investig Drugs"},{"key":"BFsrep20609_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1164\/rccm.200206-613OC","volume":"167","author":"R Arens","year":"2003","unstructured":"Arens, R. et al. Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 167, 65\u201370 (2003).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep20609_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/sleep\/27.5.997","volume":"27","author":"R Arens","year":"2004","unstructured":"Arens, R. & Marcus, C. L. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 27, 997\u20131019 (2004).","journal-title":"Sleep"},{"key":"BFsrep20609_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/CMR.13.3.470","volume":"13","author":"MW Cunningham","year":"2000","unstructured":"Cunningham, M. W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470\u2013511 (2000).","journal-title":"Clin Microbiol Rev"},{"key":"BFsrep20609_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/187152612801319230","volume":"12","author":"D Sidell","year":"2012","unstructured":"Sidell, D. & Shapiro, N. L. Acute tonsillitis. Infect Disord Drug Targets 12, 271\u20136 (2012).","journal-title":"Infect Disord Drug Targets"},{"key":"BFsrep20609_CR14","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00431-014-2395-2","volume":"173","author":"D Van Brusselen","year":"2014","unstructured":"Van Brusselen, D. et al. Streptococcal pharyngitis in children: to treat or not to treat? Eur J Pediatr 173, 1275\u201383 (2014).","journal-title":"Eur J Pediatr"},{"key":"BFsrep20609_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0165-5876(95)01316-4","volume":"35","author":"M Bussi","year":"1996","unstructured":"Bussi, M. et al. Expression of antigens associated with the individual stages of the inflammatory response in child and adult as a possible distinctive method for recurrent and chronic tonsillitis. Int J Pediatr Otorhinolaryngol 35, 243\u201350 (1996).","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"BFsrep20609_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2222.2006.02498.x","volume":"36","author":"M Peters-Golden","year":"2006","unstructured":"Peters-Golden, M., Gleason, M. M. & Togias, A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 36, 689\u2013703 (2006).","journal-title":"Clin Exp Allergy"},{"key":"BFsrep20609_CR17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1164\/rccm.200408-1064OC","volume":"172","author":"AD Goldbart","year":"2005","unstructured":"Goldbart, A. D., Goldman, J. L., Veling, M. C. & Gozal, D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 172, 364\u201370 (2005).","journal-title":"Am J Respir Crit Care Med"},{"key":"BFsrep20609_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1378\/chest.07-2746","volume":"134","author":"AG Kaditis","year":"2008","unstructured":"Kaditis, A. G. et al. Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 134, 324\u201331 (2008).","journal-title":"Chest"},{"key":"BFsrep20609_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1203\/PDR.0b013e3181b453e3","volume":"66","author":"J Kim","year":"2009","unstructured":"Kim, J. et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res 66, 423\u20138 (2009).","journal-title":"Pediatr Res"},{"key":"BFsrep20609_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.sleep.2012.03.010","volume":"13","author":"M Tsaoussoglou","year":"2012","unstructured":"Tsaoussoglou, M. et al. Cysteinyl leukotriene receptors in tonsillar B- and T-lymphocytes from children with obstructive sleep apnea. Sleep Med 13, 879\u201385 (2012).","journal-title":"Sleep Med"},{"key":"BFsrep20609_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1378\/chest.08-2102","volume":"135","author":"E Dayyat","year":"2009","unstructured":"Dayyat, E. et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 135, 1142\u20139 (2009).","journal-title":"Chest"},{"key":"BFsrep20609_CR22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/iai.50.3.844-851.1985","volume":"50","author":"KD Bremm","year":"1985","unstructured":"Bremm, K. D. et al. Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun 50, 844\u201351 (1985).","journal-title":"Infect Immun"},{"key":"BFsrep20609_CR23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1084\/jem.20041215","volume":"200","author":"JM Park","year":"2004","unstructured":"Park, J. M., Ng, V. H., Maeda, S., Rest, R. F. & Karin, M. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med 200, 1647\u201355 (2004).","journal-title":"J Exp Med"},{"key":"BFsrep20609_CR24","doi-asserted-by":"publisher","first-page":"38969","DOI":"10.1074\/jbc.M509352200","volume":"280","author":"HY Qi","year":"2005","unstructured":"Qi, H. Y. & Shelhamer, J. H. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem 280, 38969\u201375 (2005).","journal-title":"J Biol Chem"},{"key":"BFsrep20609_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/lary.20147","volume":"119","author":"LD Serpero","year":"2009","unstructured":"Serpero, L. D. et al. A mixed cell culture model for assessment of proliferation in tonsillar tissues from children with obstructive sleep apnea or recurrent tonsillitis. Laryngoscope 119, 1005\u201310 (2009).","journal-title":"Laryngoscope"},{"key":"BFsrep20609_CR26","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/mol.105.019695","volume":"69","author":"M Ii","year":"2006","unstructured":"Ii, M. et al. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol 69, 1288\u201395 (2006).","journal-title":"Mol Pharmacol"},{"key":"BFsrep20609_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","volume":"584","author":"T Kawamoto","year":"2008","unstructured":"Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y. & Kimura, H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 584, 40\u20138 (2008).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep20609_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-5793(95)00357-F","volume":"364","author":"A Cuenda","year":"1995","unstructured":"Cuenda, A. et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364, 229\u201333 (1995).","journal-title":"FEBS Lett"},{"key":"BFsrep20609_CR29","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.4049\/jimmunol.179.10.7059","volume":"179","author":"EJ Swindle","year":"2007","unstructured":"Swindle, E. J., Coleman, J. W., DeLeo, F. R. & Metcalfe, D. D. FcepsilonRI- and Fcgamma receptor-mediated production of reactive oxygen species by mast cells is lipoxygenase- and cyclooxygenase-dependent and NADPH oxidase-independent. J Immunol 179, 7059\u201371 (2007).","journal-title":"J Immunol"},{"key":"BFsrep20609_CR30","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","volume":"269","author":"D Derossi","year":"1994","unstructured":"Derossi, D., Joliot, A. H., Chassaing, G. & Prochiantz, A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269, 10444\u201350 (1994).","journal-title":"J Biol Chem"},{"key":"BFsrep20609_CR31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4049\/jimmunol.175.1.494","volume":"175","author":"VU Toshchakov","year":"2005","unstructured":"Toshchakov, V. U., Basu, S., Fenton, M. J. & Vogel, S. N. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J Immunol 175, 494\u2013500 (2005).","journal-title":"J Immunol"},{"key":"BFsrep20609_CR32","doi-asserted-by":"publisher","first-page":"e00387","DOI":"10.1128\/mBio.00387-12","volume":"4","author":"E Chiarot","year":"2013","unstructured":"Chiarot, E. et al. Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence. MBio 4, e00387\u201312 (2013).","journal-title":"MBio"},{"key":"BFsrep20609_CR33","doi-asserted-by":"publisher","first-page":"e9452","DOI":"10.1371\/journal.pone.0009452","volume":"5","author":"AE Zautner","year":"2010","unstructured":"Zautner, A. E. et al. Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One 5, e9452 (2010).","journal-title":"PLoS One"},{"key":"BFsrep20609_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","volume":"9","author":"AC Steer","year":"2009","unstructured":"Steer, A. C., Law, I., Matatolu, L., Beall, B. W. & Carapetis, J. R. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9, 611\u20136 (2009).","journal-title":"Lancet Infect Dis"},{"key":"BFsrep20609_CR35","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1128\/JCM.02155-08","volume":"47","author":"B Luca-Harari","year":"2009","unstructured":"Luca-Harari, B. et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47, 1155\u201365 (2009).","journal-title":"J Clin Microbiol"},{"key":"BFsrep20609_CR36","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1128\/JCM.00513-07","volume":"45","author":"R Creti","year":"2007","unstructured":"Creti, R. et al. emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years? J Clin Microbiol 45, 2249\u201356 (2007).","journal-title":"J Clin Microbiol"},{"key":"BFsrep20609_CR37","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1017\/S0950268805004140","volume":"133","author":"M Mencarelli","year":"2005","unstructured":"Mencarelli, M. et al. Group A streptococcal infections: trend and strain emm typing in an area of central Italy, 1985-2002. Epidemiol Infect 133, 1107\u201311 (2005).","journal-title":"Epidemiol Infect"},{"key":"BFsrep20609_CR38","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1073\/pnas.051429498","volume":"98","author":"I Walev","year":"2001","unstructured":"Walev, I. et al. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci USA 98, 3185\u201390 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep20609_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1096\/fj.01-0572fje","volume":"16","author":"I Walev","year":"2002","unstructured":"Walev, I. et al. Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream events. FASEB J 16, 237\u20139 (2002).","journal-title":"FASEB J"},{"key":"BFsrep20609_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1348-0421.2012.00426.x","volume":"56","author":"E Babolewska","year":"2012","unstructured":"Babolewska, E., Witczak, P., Pietrzak, A. & Brzezinska-Blaszczyk, E. Different potency of bacterial antigens TLR2 and TLR4 ligands in stimulating mature mast cells to cysteinyl leukotriene synthesis. Microbiol Immunol 56, 183\u201390 (2012).","journal-title":"Microbiol Immunol"},{"key":"BFsrep20609_CR41","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1138963","volume":"316","author":"V Mata-Haro","year":"2007","unstructured":"Mata-Haro, V. et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628\u201332 (2007).","journal-title":"Science"},{"key":"BFsrep20609_CR42","doi-asserted-by":"publisher","first-page":"31982","DOI":"10.1074\/jbc.M109.046383","volume":"284","author":"C Cekic","year":"2009","unstructured":"Cekic, C. et al. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem 284, 31982\u201391 (2009).","journal-title":"J Biol Chem"},{"key":"BFsrep20609_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1165\/rcmb.2005-0068OC","volume":"34","author":"DW Perng","year":"2006","unstructured":"Perng, D. W. et al. Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 34, 101\u20137 (2006).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFsrep20609_CR44","first-page":"1154","volume":"11","author":"D Passali","year":"2004","unstructured":"Passali, D. et al. Structural and immunological characteristics of chronically inflamed adenotonsillar tissue in childhood. Clin Diagn Lab Immunol 11, 1154\u20137 (2004).","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFsrep20609_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1542\/peds.110.1.7","volume":"110","author":"JL Paradise","year":"2002","unstructured":"Paradise, J. L. et al. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 110, 7\u201315 (2002).","journal-title":"Pediatrics"},{"key":"BFsrep20609_CR46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000338818","volume":"159","author":"R Ilarraza","year":"2012","unstructured":"Ilarraza, R., Wu, Y. & Adamko, D. J. Montelukast inhibits leukotriene stimulation of human dendritic cells in vitro . Int Arch Allergy Immunol 159, 422\u20137 (2012).","journal-title":"Int Arch Allergy Immunol"},{"key":"BFsrep20609_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/1547691X.2012.700652","volume":"10","author":"OV Glushkova","year":"2013","unstructured":"Glushkova, O. V. et al. Inhibitors of TLR-4, NF-kappaB, and SAPK\/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells. J Immunotoxicol 10, 133\u201340 (2013).","journal-title":"J Immunotoxicol"},{"key":"BFsrep20609_CR48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1165\/rcmb.2013-0130OC","volume":"50","author":"H Kusagaya","year":"2014","unstructured":"Kusagaya, H. et al. Toll-like receptor-mediated airway IL-17C enhances epithelial host defense in an autocrine\/paracrine manner. Am J Respir Cell Mol Biol 50, 30\u20139 (2014).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFsrep20609_CR49","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.ijporl.2012.09.003","volume":"76","author":"J Cheng","year":"2012","unstructured":"Cheng, J. & Javia, L. Methicillin-resistant Staphylococcus aureus (MRSA) pediatric tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol 76, 1795\u20138 (2012).","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"BFsrep20609_CR50","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/IAI.69.2.822-831.2001","volume":"69","author":"MS Chaussee","year":"2001","unstructured":"Chaussee, M. S., Watson, R. O., Smoot, J. C. & Musser, J. M. Identification of Rgg-regulated exoproteins of Streptococcus pyogenes . Infect Immun 69, 822\u201331 (2001).","journal-title":"Infect Immun"},{"key":"BFsrep20609_CR51","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1309\/AJCPDQNP2U5DZHVV","volume":"136","author":"MK Kjeldsen","year":"2011","unstructured":"Kjeldsen, M. K. et al. Multiparametric flow cytometry for identification and fluorescence activated cell sorting of five distinct B-cell subpopulations in normal tonsil tissue. Am J Clin Pathol 136, 960\u20139 (2011).","journal-title":"Am J Clin Pathol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep20609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20609","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:06:05Z","timestamp":1672887965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep20609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,2,22]]}},"alternative-id":["BFsrep20609"],"URL":"https:\/\/doi.org\/10.1038\/srep20609","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]},"assertion":[{"value":"22 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ADL has a personal fee from Merck Sharp and Dohme, ADL, MF, LS, AR and CB have done contract research for Novartis Vaccine and Diagnostics S.r.l. on behalf of the Hospital University of Siena, Italy. SL has acted as a consultant for Novartis Vaccine and Diagnostics S.r.l. on behalf of the Hospital University of Siena, Italy. MAB holds Novartis Vaccine and Diagnostics S.r.l. stock options. EF, SM, ST, OF, PR, MAB and AGOM are employees of Novartis Vaccine and Diagnostics S.r.l., who, working to develop an effective vaccine against GAS infection, has produced a family of pending or issued patents, regarding SLO mutant vaccine antigen listed below: PI0821240-6; 2709927; 200880126781.1; EP2235046; 12178329.4; 2339\/KOLNP\/2010; 2010-538946; 2013-211628; 10-2010-7016353; 292215; 586430; 601543; 2010130338; 163666; 8039005; 8409589 and 7731978. Furthermore, AGOM is among authors of the following Novartis Vaccine and Diagnostics patents regarding SLO protein: 2009334428 issued, a patent 2013203063 pending, a patent PI0919236-0 pending, a patent 2737453 pending, a patent 200980142304.9 pending, a patent 09786278.3 pending, a patent 12100678.5 pending, a patent 1427\/KOLNP\/2011 pending, a patent 2011-527423 pending, a patent MX\/a\/2011\/002760 issued, a patent 591633 issued, a patent 12\/561619 pending, and a patent 2011\/02005 pending. EV has been recipient of a Novartis Vaccine and Diagnostics S.r.l. Fellowship from the PhD program of the University of Siena.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20609"}}